The power of genomics, metabolomics, and other omics for target identification and validation

David M. Pereira, João C. Fernandes

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

The application of omics ranges from drug discovery and development to diagnosis of diseases, by following their progression, improving efficacy and safety of treatments, optimizing patient selection and identification of responders/nonresponders, adapting dose regimens of drugs, and helping to decide which therapy is most appropriate. For obvious reasons an integrated approach should be followed as a strategy to avoid misinterpretations of data. For example, changes found at the gene level may not necessarily translate into altered levels of proteins. Here, we address the basis of genomics and metabolomics, highlighting the most used techniques in each case and its current and future applications in human health and disease.

Original languageEnglish
Title of host publicationPrinciples of translational science in medicine
Subtitle of host publicationfrom bench to bedside, third edition
EditorsMartin Wehling
PublisherElsevier
Pages33-48
Number of pages16
Edition3
ISBN (Electronic)9780128204931
ISBN (Print)9780323999625
DOIs
Publication statusPublished - 1 Jan 2021

Keywords

  • Biomarkers
  • Metabolomics
  • Omics technologies
  • Proteomics
  • Transcriptomics

Fingerprint

Dive into the research topics of 'The power of genomics, metabolomics, and other omics for target identification and validation'. Together they form a unique fingerprint.

Cite this